Curative received FDA emergency use authorization for its novel COVID-19 tests
TechCrunch LA
APRIL 18, 2020
The diagnostics startup Curative has received an emergency use authorization from the Food and Drug Administration for its novel test to determine COVID-19 infection. Doing so will help us avoid buying materials that would constrain public health and CDC laboratories from ramping up production,” the company said on its website.
Let's personalize your content